BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 20170026)

  • 21. Gynecologic malignancies of the elderly.
    Weintraub NT; Freedman ML
    Clin Geriatr Med; 1987 Nov; 3(4):669-94. PubMed ID: 3315162
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinical analysis of 42 cases of primary malignant melanoma in female genital tract].
    An JS; Wu LY; Li N; Li B; Yu GZ; Liu LY
    Zhonghua Fu Chan Ke Za Zhi; 2007 May; 42(5):320-4. PubMed ID: 17673044
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gynaecological cancers in Umbria (Italy): trends of incidence, mortality and survival, 1978-1998.
    Minelli L; Stracci F; Prandini S; Moffa IF; La Rosa F
    Eur J Obstet Gynecol Reprod Biol; 2004 Jul; 115(1):59-65. PubMed ID: 15223167
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pap screening and knowledge of risk factors for cervical cancer in Chinese women in British Columbia, Canada.
    Hislop TG; Teh C; Lai A; Ralston JD; Shu J; Taylor VM
    Ethn Health; 2004 Aug; 9(3):267-81. PubMed ID: 15370000
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Knowledge, behavior, and fears concerning breast and cervical cancer among older low-income Mexican-American women.
    Suarez L; Roche RA; Nichols D; Simpson DM
    Am J Prev Med; 1997; 13(2):137-42. PubMed ID: 9088451
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Constitutive characteristics and change trend of gynecological malignant tumors in 8009 hospitalized patients in Guangxi Zhuang Autonomous Region].
    Huang W; Li L; Yu DQ; Huang YL; Liu Y; Chen XQ; Tang BJ; Xu H; Ma G; Dong LH; Li L; Qiu Y; Bai H; Nong WZ; Li L; Zeng DY; Jiang FY; Lan Y; Ye Y; Tang XZ; Wang DX; Li HZ; Pan YB; Mo AX; Wu XY; Lei ZY; Zhou GP; Liu C; Su QH
    Zhonghua Fu Chan Ke Za Zhi; 2007 Jan; 42(1):22-5. PubMed ID: 17331416
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical aspects of gynecological cancers' prophylaxis.
    Zlatkov V; Kostova P
    J BUON; 2006; 11(4):439-45. PubMed ID: 17309175
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Postpartum diabetes screening in women with a history of gestational diabetes.
    Smirnakis KV; Chasan-Taber L; Wolf M; Markenson G; Ecker JL; Thadhani R
    Obstet Gynecol; 2005 Dec; 106(6):1297-303. PubMed ID: 16319255
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Healthcare resource use and costs associated with cervical, vaginal and vulvar cancers in a large U.S. health plan.
    Insinga RP; Ye X; Singhal PK; Carides GW
    Gynecol Oncol; 2008 Nov; 111(2):188-96. PubMed ID: 18757080
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Updated approach to screening for cervical cancer in older women.
    Celentano DD
    Geriatrics; 1988 Apr; 43(4):37-8, 40-4, 48. PubMed ID: 2832258
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Knowledge and awareness of cervical cancer and screening among Malaysian women who have never had a Pap smear: a qualitative study.
    Wong LP; Wong YL; Low WY; Khoo EM; Shuib R
    Singapore Med J; 2009 Jan; 50(1):49-53. PubMed ID: 19224084
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Awareness of breast and cervical cancer risk factors and screening behaviours among nurses in rural region of Turkey.
    Yaren A; Ozkilinc G; Guler A; Oztop I
    Eur J Cancer Care (Engl); 2008 May; 17(3):278-84. PubMed ID: 18419631
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of PET in gynecologic malignancy.
    Grigsby PW
    Curr Opin Oncol; 2009 Sep; 21(5):420-4. PubMed ID: 19553814
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Breast and cervical cancer screening among Appalachian women.
    Hall HI; Uhler RJ; Coughlin SS; Miller DS
    Cancer Epidemiol Biomarkers Prev; 2002 Jan; 11(1):137-42. PubMed ID: 11815412
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mortality rates due to gynecologic cancers in New York state by demographic factors and proximity to a Gynecologic Oncology Group member treatment center: 1979-2001.
    Tan W; Stehman FB; Carter RL
    Gynecol Oncol; 2009 Aug; 114(2):346-52. PubMed ID: 19411096
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Decline in cervical cancer incidence and mortality in New South Wales in relation to control activities (Australia).
    Taylor R; Morrell S; Mamoon H; Wain G; Ross J
    Cancer Causes Control; 2006 Apr; 17(3):299-306. PubMed ID: 16489537
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical applications of urinary gonadotropin peptides (UGP) in gynecologic oncology.
    Schwartz PE; Cracchiolo BM; Cole LA
    Anticancer Res; 1996; 16(4B):2135-9. PubMed ID: 8694533
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Cervical cancer screening: current status and perspectives].
    Petignat P; Bouchardy C; Sauthier P
    Rev Med Suisse; 2006 May; 2(66):1308-9, 1311-2. PubMed ID: 16775991
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical inquiry: do annual pelvic exams benefit asymptomatic women who receive regular Pap smears?
    Gold E; Guthmann R; Plonka C
    J Fam Pract; 2015 Jan; 64(1):51-2, 65. PubMed ID: 25574511
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Results and perspectives of research in oncological gynecology].
    Bokhman IaV; Nechaeva ID
    Akush Ginekol (Mosk); 1982 Oct; (10):5-8. PubMed ID: 7181000
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.